相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 技术资料
- 保存条件:
Powder: -20°C, 3 years; 4°C, 2 years. In solvent: -80°C, 6 months; -20°C, 1 month.
- 英文名:
Bromovalerylurea
- 库存:
货期:1-2天
- 供应商:
MedChemExpress LLC
- CAS号:
496-67-3
- 规格:
10 mM * 1 mL/500 mg/1 g
| 规格: | 10 mM * 1 mL | 产品价格: | ¥500.0 |
|---|---|---|---|
| 规格: | 500 mg | 产品价格: | ¥400.0 |
| 规格: | 1 g | 产品价格: | ¥550.0 |
MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
Bromisoval
CAS No. : 496-67-3
MCE 国际站:Bromisoval
产品活性:Bromisoval(BU)具有抗炎作用。
研究领域:Others
作用靶点:Others
In Vitro: Bromisoval (BU) suppresses nitric oxide (NO) releasing and proinflammatory cytokine expression in lipopolysaccharide (LPS)-treat BV2 cells, a murine microglial cell line. Bromisoval suppresses LPS-inducing phosphorylation of signal transducer and activator of transcription 1 (STAT1) and expression of interferon regulatory factor 1 (IRF1). The Janus kinase 1 (JAK1) inhibitor filgotinib suppresses the NO release much more weakly than that of Bromisoval, although filgotinib almost completely prevents LPS-inducing STAT1 phosphorylation. Knockdown of JAK1, STAT1, or IRF1 does not affect the suppressive effects of Bromisoval on LPS-inducing NO. A combination of Bromisoval and filgotinib synergistically suppress the NO releasing. The mitochondrial complex I inhibitor rotenone, which does not prevent STAT1 phosphorylation or IRF1 expression, suppresses proinflammatory mediator expression less significantly than Bromisoval. Bromisoval and rotenone reduce intracellular ATP (iATP) levels to a similar extent. A combination of rotenone and filgotinib suppress NO release in LPS-treated BV2 cells as strongly as Bromisoval.
In Vivo: Bromisoval (Bromvaletone) and carbromal are the most potent central depressants within each series. Depressant activities (ISD50 values) and acute toxicities (LD50 values) in male mice after intraperitoneal injection of Bromisoval are 0.35 (0.30-0.39) and 3.25 (2.89-3.62) mmol/kg, respectively.
相关产品:Drug Repurposing Compound Library Plus | FDA-Approved Drug Library Plus | FDA-Approved Drug Library Mini | Bioactive Compound Library Plus | Immunology/Inflammation Compound Library | FDA-Approved Drug Library | Drug Repurposing Compound Library | Anti-COVID-19 Compound Library | NMPA-Approved Drug Library | FDA Approved & Pharmacopeial Drug Library | Drug-Induced Liver Injury (DILI) Compound Library | Off-patent Drug Library | Cysteine Targeted Covalent Library | Cysteine Targeted Covalent Fragment Library | Digitonin | 5-Ph-IAA | FLAG peptide | Tocofersolan | Monocrotaline | Lactate sodium | TCEP hydrochloride | 3X FLAG peptide | DPPH | Pertussis Toxin | Pronase E (Activity ≥ 7000 U/g) | O-Propargyl-Puromycin | NMDI14 | Phytohemagglutinin | MYLS22 | Hyaluronidase | Biotinyl tyramide | Kifunensine | Human IgG1 kappa, Isotype Control | 4-Azido-L-phenylalanine | 6-Aminonicotinamide | Ammonium tetrathiomolybdate(VI) | OVA Peptide(257-264) TFA | Alkyne-phenol | Lauryl maltose neopentyl glycol | SHIN1 | CHAPS | Cytosporone B
热门产品线:重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
技术资料暂无技术资料 索取技术资料

















